Company Advanced Proteome Therapeutics Corp. Toronto S.E.
Equities
CA0076281009
Investment Holding Companies
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/18/16 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10/09/10 |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21/22/21 |
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/18/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,127,080 | 36,950,363 ( 89.84 %) | 0 | 89.84 % |
Company contact information
Advanced Proteome Therapeutics Corp.
8337 Eastlake Drive Suite 104
V5A 4W2, Burnaby
+(604) 690-3797
![address Advanced Proteome Therapeutics Corp.](https://cdn.zonebourse.com/static/address/49477459.png)
1st Jan change | Capi. | |
---|---|---|
+52.86% | 553.25Cr | |
+98.02% | 123.22Cr | |
+2.67% | 99Cr | |
+17.83% | 78Cr | |
+2.06% | 67Cr | |
+5.03% | 63Cr | |
-.--% | 60Cr | |
+11.39% | 53Cr | |
-.--% | 50Cr |